Testing effectiveness (Phase 2)Looking for participantsNCT05646381
What this trial is testing
Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Who this might be right for
Aortic Stenosis
Novartis Pharmaceuticals 502